Indivior Pharmaceuticals Inc (INDV)
Indivior Pharmaceuticals stock today
Indivior Pharmaceuticals closed at $35.37 on October 30, 2026, up 0.34% on the day. Over the past year it returned +21.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.17 billion.
| Period | INDV | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.3% | -0.9% |
| 3 months | -12.1% | +2.1% |
| Year to date | -1.4% | +11.7% |
| 1 year | +21.4% | +12.4% |
| 3 years | +80.5% | +88.5% |
| 5 years | +108.7% | +76.0% |
Key statistics
- Market value
- $4.17B
- P/E (trailing)
- 9.9
- Forward P/E
- 7.9
- Price / sales
- 3.0
- 52-week range
- $28.78 to $41.83
About Indivior Pharmaceuticals
Indivior develops and commercializes treatments for opioid use disorder and other behavioral health conditions.
Sector: Health Care
More on Indivior Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +4% in the year to Dec 2025
- Valuation: P/E history and peersP/E 9.9
- Returns: what $1,000 became$1,000 ten years ago is $1,823 today
No forecast, no recommendation. This page describes Indivior Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.